Hillenbrand Completes Sale of Majority Stake in Milacron Injection Molding and Extrusion Business

Core Viewpoint - Hillenbrand, Inc. has completed the sale of its majority interest in the Milacron injection molding and extrusion business to Bain Capital for $287 million, retaining a 49% ownership stake [1][2][3] Group 1: Transaction Details - Bain Capital now holds approximately 51% of Milacron and has full operational control, while Hillenbrand retains a 49% stake [2] - The transaction is expected to yield after-tax net proceeds of approximately$ 250 million for Hillenbrand, which will be used to pay down debt [4] Group 2: Strategic Implications - This sale reflects Hillenbrand's ongoing transformation into a pure-play industrial company, allowing it to focus on core process and automation equipment for food, pharmaceutical, and polymer markets [3] - The partnership with Bain Capital is anticipated to enhance Milacron's growth potential and operational success, leveraging Bain's resources and focus [4] Group 3: Historical Context - Hillenbrand acquired Milacron Holdings Corp. in 2019, which included Milacron's injection molding and extrusion business, along with Mold-Masters, DME, and Cimcool [3] - Hillenbrand previously sold the Cimcool business in 2020 and continues to own Mold-Masters and DME [3]